Health Trials

Clinical trials

2

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Safety and Efficacy of STL303 In Patients With Primary Immunoglobulin A (IgA) Nephropathy

This is a multicenter, randomized, double-blind, placebo controlled Phase IIb study to explore the efficacy and safety of STL303 capsules in IgAN patients. About 15 patients dignosed with primary IgAN will be enrolled and randomized to three cohorts and take different dosage of STL303 or placebo capsules orally according to protocol.

Participants needed: 15
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Sitala Bio LTDUpdated: May 28, 2026Locations: 3
Eligibility criteria

eGFR (Chronic Kidney Disease Epidemiology Collaboration [CKD-EPI] formula) great... [+4]

Secondary IgAN or unclear exclusion of secondary causes. [+15]

Read more
Status: Not yet recruiting

A Study in Adults With Geographic Atrophy

The purpose of this clinical research study is to look at how safe STL303 is and whether it works when given to people with Geographic Atrophy (GA) secondary to Age-related Macular Degeneration (AMD). Geographic atrophy secondary to AMD is a condition where cells in the back part of the eye slowly die, causing a blurry, or missing spot in the centre of vision.

Participants needed: 300
Trial details
Phase: Phase 2Age: 60+Biological sex: AllType: InterventionalSponsor: Sitala Bio LTDUpdated: May 28, 2026Locations: 60
Eligibility criteria

Participants ≥60 years of age at the time of Screening (signing the ICF). [+21]

Atrophic retinal disease of causality other than AMD including myopia-related ma... [+33]

Read more